Ophthalmology

Data Safety Monitoring Board Approves Third Cohort in Advanced Cell Technology Clinical Trials

The Data Safety Monitoring Board has given Advanced Cell Technology approval to treat patients in the third cohort of each of the company’s three stem cell clinical trials, according to a report by the Fort Mill Times.

Carrie Pallardy

Thursday, March 14th, 2013

Advanced Cell Technology, a Santa Monica, Calif.-based regenerative medicine company, is also working towards a macular degeneration treatment in two clinical trials recently approved by the FDA.

More Articles on Ophthalmology:
EyeTechCare Receives $13M in Funding
10 Statistics on Ophthalmologist Compensation by Location
Dr. Andrew Holzman to Participate in FDA Trial

Next Up in Ophthalmology

Prism adds Washington eye group to national network

Spokane (Wash.) Eye Clinic has joined Prism Vision Group’s network of affiliated practices. The affiliation expands Prism’s geographic reach beyond…

By: Sophie Eydis
Thursday, November 6th, 2025
Bascom Palmer Eye Institute to open 1st international facility

Bascom Palmer Eye Institute, part of UHealth – University of Miami Health System, is opening a facility in Abu Dhabi,…

By: Cameron Cortigiano
Thursday, October 30th, 2025
AmSurg acquires South Carolina ASC

Nashville, Tenn.-based AmSurg has acquired Surgery Center of Conway (S.C.), marking the organization’s fourth facility based in South Carolina. Surgery…

By: Cameron Cortigiano
Tuesday, October 28th, 2025

Comments are closed.

Innovating for inclusion: How health systems are rethinking language access

Next Up in Ophthalmology

Prism adds Washington eye group to national network

Bascom Palmer Eye Institute to open 1st international facility

AmSurg acquires South Carolina ASC

Join the 40,000+ ASC leaders who start their day with Becker's